Search

Displaying results 5271 - 5280 of 8517 in total
  1. Drug

    Amfonelic acid

    go.drugbank.com/drugs/DB21147
    Experimental

    Amfonelic acid has a monoisotopic molecular weight of 308.12 Da.

  2. Drug

    Xanoxic acid

    go.drugbank.com/drugs/DB21173
    Experimental

    Xanoxic acid has a monoisotopic molecular weight of 298.08 Da.

  3. Drug

    Tizoprolic acid

    go.drugbank.com/drugs/DB21293
    Experimental

    Tizoprolic acid has a monoisotopic molecular weight of 171.04 Da.

  4. Drug

    Hydroxytoluic acid

    go.drugbank.com/drugs/DB21441
    Experimental

    Hydroxytoluic acid has a monoisotopic molecular weight of 152.05 Da.

  5. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  6. Drug

    Protocatechualdehyde

    go.drugbank.com/drugs/DB11268
    Approved

    Also known as protocatechuic aldehyde, protocatechualdehyde is a naturally-occuring phenolic aldehyde that is found in barley, green cavendish bananas, grapevine leaves and root of the herb S. miltiorrhiza

  7. Drug

    Teriflunomide

    go.drugbank.com/drugs/DB08880
    ApprovedInvestigational

    Teriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis.

  8. Drug

    Meclizine

    go.drugbank.com/drugs/DB00737
    ApprovedInvestigational

    [L6760] Commonly marketed under the brand name Antivert in the U.S., meclizine is available as oral tablets.

  9. Drug

    Boron

    go.drugbank.com/drugs/DB11203
    ApprovedInvestigational

    There are few pharmaceutical agents that contain a boron molecule in their structures, such as [DB09041] and [DB00188]. … Boric acid contains antiseptic, antifungal, and antiviral properties thus it is used as a water clarifier in swimming pool water treatment.

  10. Drug

    Ambrisentan

    go.drugbank.com/drugs/DB06403
    ApprovedInvestigational

    It is approved in Europe, Canada and the United States for use as a single agent to improve exercise ability and delay clinical worsening. … As an endothelin receptor antagonist, Ambrisentan prevents endogenous endothelin peptide from constricting the muscles in blood vessels, allowing them to relax and permit a reduction in blood pressure.